Update shared on04 Sep 2025
With minimal changes in both the discount rate and future P/E, Beyond Air’s consensus analyst price target remained effectively unchanged at $11.20.
What's in the News
- Expanded global LungFit PH distribution network to 34 countries, including new agreements in Japan (with AMCO), South Korea, Costa Rica, Guatemala, and El Salvador.
- Awarded a national group purchasing agreement with Premier, Inc., granting Premier members access to special pricing and terms for LungFit PH and NO2 Smart Filters, supported by HealthCare Links.
- Conducted a 1:20 stock split.
- Received an unqualified audit opinion with going concern doubts in latest 10-K filing by Marcum LLP.
- Submitted a PMA supplement to the FDA for LungFit PH II, a next-generation system designed to be smaller, lighter, and transport-ready, maintaining compatibility with current Smart Filters.
Valuation Changes
Summary of Valuation Changes for Beyond Air
- The Consensus Analyst Price Target remained effectively unchanged, at $11.20.
- The Discount Rate for Beyond Air remained effectively unchanged, moving only marginally from 9.67% to 9.74%.
- The Future P/E for Beyond Air remained effectively unchanged, moving only marginally from 142.48x to 142.74x.
Disclaimer
AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.